Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23976849)

1.

Process optimization and evaluation of novel baicalin solid nanocrystals.

Yue PF, Li Y, Wan J, Wang Y, Yang M, Zhu WF, Wang CH, Yuan HL.

Int J Nanomedicine. 2013;8:2961-73. doi: 10.2147/IJN.S44924. Epub 2013 Aug 9.

2.

Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.

Shi-Ying J, Jin H, Shi-Xiao J, Qing-Yuan L, Jin-Xia B, Chen HG, Rui-Sheng L, Wei W, Hai-Long Y.

Chin J Nat Med. 2014 Jan;12(1):71-80. doi: 10.1016/S1875-5364(14)60012-1.

PMID:
24484600
3.

A novel high-pressure precipitation tandem homogenization technology for drug nanocrystals production - a case study with ursodeoxycholic acid.

Li Y, Wang Y, Yue PF, Hu PY, Wu ZF, Yang M, Yuan HL.

Pharm Dev Technol. 2014 Sep;19(6):662-70. doi: 10.3109/10837450.2013.819015. Epub 2013 Jul 22.

PMID:
23869484
4.

[Preparation of baicalin nanocrystal pellets and preliminary study on its pharmacokinetics].

Jin SY, Yuan HL, Jin SX, Lv QY, Bai JX, Han J.

Zhongguo Zhong Yao Za Zhi. 2013 Apr;38(8):1156-9. Chinese.

PMID:
23944028
5.

Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.

Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.

J Pharm Pharm Sci. 2011;14(2):196-214.

6.

Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design.

Hao J, Wang F, Wang X, Zhang D, Bi Y, Gao Y, Zhao X, Zhang Q.

Eur J Pharm Sci. 2012 Sep 29;47(2):497-505. doi: 10.1016/j.ejps.2012.07.006. Epub 2012 Jul 20.

PMID:
22820033
7.

Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation.

Zhao L, Wei Y, Huang Y, He B, Zhou Y, Fu J.

Int J Nanomedicine. 2013;8:3769-79. doi: 10.2147/IJN.S51578. Epub 2013 Oct 2.

8.

Preparation and characterization of quercetin nanocrystals.

Sahoo NG, Kakran M, Shaal LA, Li L, Müller RH, Pal M, Tan LP.

J Pharm Sci. 2011 Jun;100(6):2379-90. doi: 10.1002/jps.22446. Epub 2010 Dec 23.

PMID:
21491450
9.

Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension.

Li W, Yang Y, Tian Y, Xu X, Chen Y, Mu L, Zhang Y, Fang L.

Int J Pharm. 2011 Apr 15;408(1-2):157-62. doi: 10.1016/j.ijpharm.2011.01.059. Epub 2011 Feb 2.

PMID:
21295124
10.

Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.

Wang L, Hao Y, Liu N, Ma M, Yin Z, Zhang X.

Drug Dev Ind Pharm. 2012 Nov;38(11):1381-9. Epub 2012 Feb 3.

PMID:
22300415
11.

Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.

Quan P, Xia D, Piao H, Piao H, Shi K, Jia Y, Cui F.

AAPS PharmSciTech. 2011 Dec;12(4):1136-43. doi: 10.1208/s12249-011-9682-2. Epub 2011 Sep 3.

12.

Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.

Zhang J, Huang Y, Liu D, Gao Y, Qian S.

Eur J Pharm Sci. 2013 Mar 12;48(4-5):740-7. doi: 10.1016/j.ejps.2012.12.026. Epub 2013 Jan 7.

PMID:
23305994
13.

Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.

Jiang T, Han N, Zhao B, Xie Y, Wang S.

Drug Dev Ind Pharm. 2012 Oct;38(10):1230-9. doi: 10.3109/03639045.2011.645830. Epub 2012 Jan 9.

PMID:
22229827
14.

Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.

Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, Cui F.

Eur J Pharm Sci. 2010 Jul 11;40(4):325-34. doi: 10.1016/j.ejps.2010.04.006. Epub 2010 Apr 22.

PMID:
20417274
15.

Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.

Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ.

Int J Nanomedicine. 2011;6:2997-3009. doi: 10.2147/IJN.S26546. Epub 2011 Nov 24.

16.

Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions.

Li W, Quan P, Zhang Y, Cheng J, Liu J, Cun D, Xiang R, Fang L.

Int J Pharm. 2014 Jan 2;460(1-2):13-23. doi: 10.1016/j.ijpharm.2013.10.038. Epub 2013 Oct 29.

PMID:
24184036
17.

Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.

Guo JJ, Yue PF, Lv JL, Han J, Fu SS, Jin SX, Jin SY, Yuan HL.

Int J Pharm. 2013 Jan 30;441(1-2):227-33. doi: 10.1016/j.ijpharm.2012.11.039. Epub 2012 Dec 7.

PMID:
23220096
18.

Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal.

Zhang J, Lv H, Jiang K, Gao Y.

Int J Pharm. 2011 Nov 25;420(1):180-8. doi: 10.1016/j.ijpharm.2011.08.023. Epub 2011 Aug 22.

PMID:
21878378
19.

D-Alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensions.

Yue PF, Wan J, Wang Y, Li Y, Ma YQ, Yang M, Hu PY, Yuan HL, Wang CH.

Int J Pharm. 2013 Feb 25;443(1-2):279-87. doi: 10.1016/j.ijpharm.2012.12.036. Epub 2013 Jan 3.

PMID:
23291447
20.

Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.

Zuo B, Sun Y, Li H, Liu X, Zhai Y, Sun J, He Z.

Int J Pharm. 2013 Oct 15;455(1-2):267-75. doi: 10.1016/j.ijpharm.2013.07.021. Epub 2013 Jul 20.

PMID:
23876497
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk